ducovest

RFG:ARCA-Guggenheim S&P Midcap 400 Pure Growth (USD)

ETF | Mid-Cap Growth | NYSE Arca

Last Closing

USD 48.7757

Change

-0.49 (-1.00)%

Market Cap

USD 0.53B

Volume

9.22K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P MidCap 400? Pure Growth Index Total Return. Under normal circumstances, the fund will invest at least 90% of its net assets, plus any borrowings for investment purposes, in the equity securities included in the underlying index. The underlying index is narrow in focus, containing only those S&P MidCap 400 ? companies with strong growth characteristics as selected by S&P. The fund is non-diversified.

Company Website : www.rydex-sgi.com/

Currency: USD

Country : USA

Inception Date: 01/03/2006

Primary Benchmark: S&P MidCap 400 Pure Growth TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.35%

Management Expense Ratio: 0.35 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
AUTL Autolus Therapeutics Ltd 1.79 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth.. 0.24 %

N/A

 USD 17.84B
VOT Vanguard Mid-Cap Growth Index .. 0.07 %

N/A

 USD 15.74B
IJK iShares S&P Mid-Cap 400 Growth.. 0.24 %

N/A

 USD 9.31B
XMMO Invesco S&P MidCap Momentum ET.. 0.39 %

N/A

 USD 4.07B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.20 %

N/A

 USD 1.13B
CWS AdvisorShares Focused Equity E.. 0.68 %

N/A

 USD 0.18B
ETHO Amplify ETF Trust 0.45 %

N/A

 USD 0.18B
IPO Renaissance IPO ETF 0.60 %

N/A

 USD 0.16B
BFOR Barron's 400 ETF 0.65 %

N/A

 USD 0.15B
PEXL Pacer US Export Leaders ETF 0.60 %

N/A

 USD 0.06B

ETFs Containing RFG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.22% 69% C- 76% C+
Dividend Return 0.38% 33% F 4% F
Total Return 18.59% 69% C- 72% C
Trailing 12 Months  
Capital Gain 18.22% 69% C- 76% C+
Dividend Return 0.38% 33% F 4% F
Total Return 18.59% 69% C- 72% C
Trailing 5 Years  
Capital Gain 58.87% 56% F 78% C+
Dividend Return 3.49% 33% F 9% A-
Total Return 62.36% 56% F 75% C
Average Annual (5 Year Horizon)  
Capital Gain 11.23% 50% F 67% D+
Dividend Return 11.57% 56% F 63% D
Total Return 0.34% 28% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 32.13% 17% F 33% F
Risk Adjusted Return 36.00% 39% F 50% F
Market Capitalization 0.53B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.